Brief: Onward Says Up-LIFT Study Achieves Primary Endpoint

ONWARD Medical

13/09/2022 06:34

Sept 13 (Reuters) - Onward Medical NV  ONWD.BR :
    * ONWARD REPORTS POSITIVE TOPLINE RESULTS FROM A PIVOTAL
STUDY TO
RESTORE ARM AND HAND FUNCTION IN PEOPLE WITH SPINAL CORD INJURY
    * UP-LIFT STUDY ACHIEVES PRIMARY ENDPOINT
    * ONWARD PLANS TO SUBMIT FOR MARKETING APPROVAL IN U.S. AND
EUROPE
WITH GOAL TO LAUNCH ARC-EX THERAPY IN SECOND HALF OF 2023
    * IMPROVEMENT IN ARM AND HAND FUNCTION IS HIGHEST PRIORITY
AMONG
PEOPLE WITH TETRAPLEGIA
    * COMPANY PLANS TO SUBMIT FOR REGULATORY APPROVAL IN BOTH US
AND
EUROPE WITHIN NEXT 6 MONTHS
    * DETAILED RESULTS WILL BE MADE AVAILABLE AFTER REVIEW BY
FDA
    * WE ARE HOPEFUL WE CAN BEGIN TO POSITIVELY IMPACT LIVES OF
PEOPLE
WITH SPINAL CORD INJURY SOMETIME DURING SECOND HALF OF 2023

Source text for Eikon:  ID:nBw6Y7RtVa 
Further company coverage:  ONWD.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))